glp-1 weight loss drug news drugs and addiction: Study shows may help reduce overdose risks New studies find that GLP-1

Furthermore, current research on broad-spectrum agonists or inhibitors mostly focuses on one or two targets, lacking in-depth exploration of the crosstalk produced when the same agonist/inhibitor acts on multiple members of the SIRT/HDAC family

(US Patent 8598118) characterized hepatocyte growth factor mimics as therapeutic agents and established the mechanistic basis for Dihexas development

| Side effects compared | How to choose between them | If youre already on Mounjaro or Wegovy injections | Maintaining muscle mass | Frequently asked questions | Take home message The Wegovy pill (oral semaglutide 25 mg) is the first oral GLP-1 medication licensed for weight loss in the UK, available privately on prescription after the MHRA approved it on 11 June 2026

Fu Y, Liu S, Zeng S, Shen H